Antares Pharma, Inc. (NASDAQ:ATRS) Receives Average Recommendation of "Buy" from Analysts

Retrieved on: 2020-12-09 18:26:16

Tags for this article:

Click the tags to see associated articles and topics

Antares Pharma, Inc. (NASDAQ:ATRS) Receives Average Recommendation of "Buy" from Analysts. View article details on hiswai:

Excerpt

<b>AQR Capital Management</b> LLC now owns 851,303 shares of the specialty pharmaceutical company's stock worth $2,341,000 after acquiring an ...

Article found on: www.marketbeat.com